Cited by

• The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014.

  Ascierto PA, Addeo R, Cartenì G, Daniele B, De Laurentis M, Ianniello GP, Morabito A, Palmieri G, Pepe S, Perrone F, Pignata S, Montesarchio V. Ascierto PA, et al. J Transl Med. 2014 Oct 21;12:291. doi: 10.1186/s12967-014-0291-1. J Transl Med. 2014. PMID: 25331657 Free PMC article. Review.
• Therapeutic cancer vaccines: are we there yet?

  Klebanoff CA, Acquavella N, Yu Z, Restifo NP. Klebanoff CA, et al. Immunol Rev. 2011 Jan;239(1):27-44. doi: 10.1111/j.1600-065X.2010.00979.x. Immunol Rev. 2011. PMID: 21198663 Free PMC article. Review.
• Interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer.

  Huber ML, Haynes L, Parker C, Iversen P. Huber ML, et al. J Natl Cancer Inst. 2012 Feb 22;104(4):273-9. doi: 10.1093/jnci/djr514. Epub 2012 Jan 9. J Natl Cancer Inst. 2012. PMID: 22232132 Free PMC article.
• Improved endpoints for cancer immunotherapy trials.

  Hoos A, Eggermont AM, Janetzki S, Hodi FS, Ibrahim R, Anderson A, Humphrey R, Blumenstein B, Old L, Wolchok J. Hoos A, et al. J Natl Cancer Inst. 2010 Sep 22;102(18):1388-97. doi: 10.1093/jnci/djq310. Epub 2010 Sep 8. J Natl Cancer Inst. 2010. PMID: 20826737 Free PMC article. Review.
• Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine.

  Lai L, Kwa S, Kozlowski PA, Montefiori DC, Ferrari G, Johnson WE, Hirsch V, Villinger F, Chennareddi L, Earl PL, Moss B, Amara RR, Robinson HL. Lai L, et al. J Infect Dis. 2011 Jul 1;204(1):164-73. doi: 10.1093/infdis/jir199. J Infect Dis. 2011. PMID: 21628671 Free PMC article.